Clinical Trials
32 trialsBio-lung
University Hospital, Lille
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Vanderbilt-Ingram Cancer Center
Circulating Tumor Cells (CTC) in Lung Cancer
Indiana University
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Nucleix Ltd.
RESISTYR
Rennes University Hospital
PROACT-LUNG
Freenome Holdings Inc.
IPON-3
Maastricht Radiation Oncology
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University
Genetic Susceptibility to Lung Cancer in Never Smokers
Memorial Sloan Kettering Cancer Center
EGFR Lung Canc
Our Lady of the Lake Hospital
FUTURE
Assistance Publique Hopitaux De Marseille
Lung EpiCheck Biomarkers Development Study
Nucleix Ltd.
RICEPS
University Hospital, Tours
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
Cedars-Sinai Medical Center
DNA Repair and Genetic Susceptibility to Lung Cancer
Memorial Sloan Kettering Cancer Center
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
'Lung Health Check' Biomarker Study
Royal Marsden NHS Foundation Trust
LUN0017
Stanford University
DECAMP-1
Boston University
GOLF
Royal Marsden NHS Foundation Trust
A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer
Abramson Cancer Center at Penn Medicine
The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells
Chinese Medical Association
Personalizing Immune Checkpoint Inhibitor Therapy
Holy Cross Hospital, Maryland
MechLungCa
Washington University School of Medicine
Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer
Vanderbilt-Ingram Cancer Center
Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?
Cumhuriyet University
Metabolism of Lipids in Advanced Cancer
AHS Cancer Control Alberta
Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer
M.D. Anderson Cancer Center
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
Memorial Sloan Kettering Cancer Center
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
Memorial Sloan Kettering Cancer Center